Today

Agents

Chat

Arena

Discover

More

App

PACS Group, Inc. <PACS.N>: Oppenheimer Raises Target Price to $57 From $48 - PACS News | Rallies

PACS Group, Inc. <PACS.N>: Oppenheimer Raises Target Price to $57 From $48

PACS•2026-08-10

Related News

Conduent Q2 adjusted EBITDA drops 30.4% Y/Y to USD 16 million; revenue falls 11.9% Y/Y to USD 531 million

CNDT•2026-08-10

Voyager wins U.S. Space Force contract for resilient satellite communications development

VOYG•2026-08-10

Artelo Biosciences doses first patient in Phase 2 glaucoma trial of ART27.13

ARTL•2026-08-10

Fluor Corp <FLR.N>: UBS Raises Target Price to $66 From $59

FLR•2026-08-10

Tri-County Financial to merge into HBT Financial in $204.6 million stock-and-cash deal

HBT•2026-08-10